SynopsisSecondary oral hygiene can be described as the usage of products for the protection of gums from periodontal diseases. It includes mouthwashes, dental flosses, mouth fresheners, teeth whitening products, and mouth dentures. The global Secondary Oral Hygi.....
SynopsisLong Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be u.....
SynopsisActonel (Risedronic Acid) ( CAS 105462-24-6) The global Actonel (Risedronic Acid) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American .....
SynopsisArgininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. The global Arginase Deficiency Treatment market was valued at US$ .....
SynopsisThe Air Shield Walker is a medical device designed to support and protect the foot and ankle during the recovery from injuries, fractures, or surgical procedures. This specialized walker boot is equipped with an inflatable air bladder system that allows users .....
SynopsisThe global Allogeneic Stem Cell Therapy market was valued at US$ 757.3 million in 2023 and is anticipated to reach US$ 1499.5 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030. North American market for Allogeneic Stem Cell.....
SynopsisThe global Single-use Medical Endoscopes market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on Single-use Medical Endoscopes volume and va.....
SynopsisThe global Soft Mist Inhaler (Respimat,SMI) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Soft Mist Inhaler (Respimat,SMI) .....
SynopsisGlobal Chronic Granulomatous Disease (CGD) Management market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Ru.....
SynopsisThe global Medical Stoppers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devices is estimat.....
